1. Down JHL. Observation on an ethnic
classification of idiots. London Hosp. Clin Lect Rep 1866; 3: 259.
2. George T, Capone MD. Down Syndrome: Advance in
molecular biology and neuro-sciences. J Dev Behav Pradiatr 2001; 22:
40-59.
3. Epstein CJ. Down syndrome (trisomy 21). In:
Scriver CR, Beaudet AL, Sly WS, Valle D, Chills B, Kinzler KW and
Vogelstein B, editors. The metabolic and molecular bases of
inherited disease. 8th ed. McGraw-Hill Companies, Inc; USA, 2001. p.
1223-1256.
4. Puscal K, Marie LY. Human chromosome 21
sequence: impact for the molecular genetics of Down syndrome. Gene
Func Dis 2000; 5: 1-9.
5. Reeves RH, Baxter LL, Richtsmeier JT. Too much
good thing: mechanisms of gene action in Down syndrome. Trend Genet
2001, 17; 83-88.
6. Hattori M, Fujiyama A, Taylor TD, Watanabe H,
Yada T, Park HS, et al. The DNA sequence of human chromosome 21.
Nature 2000; 405: 311-319.
7. Progribona M, Melnyk S, Pogribona I, Chango A,
Yi P, Jill S. Homocysteine metabolism in children with Down
syndrome: in vitro modulation. Am J Hum Genet 2001; 69: 88-95.
8. Barlow GM, Chen XN, Shi ZY, Lyons GE, Kurnit
DM, Celle L, et al. Down syndrome congenital heart disease: A narrow
region and a candidate gene. Genet Med. 2001; 3: 91-101.
9. Engidawork E, Lubec G. Molecular changes in
fetal Down syndrome brain. J Neurochem 2003; 84: 895-904.
10. Lange AW, Molkentin JD, Yutzey KE. DSCR1 gene
expression is dependent on NFATc1 during cardiac valve formation and
colocalizes with anomalous organ development in trisomy 16 mice. Dev
Biol. 2004; 266: 346-360.
11. Wolvetang EJ, Bradfield OM, Hatzistavrou T,
Crack PJ, Busciglio J, Kola I, et al. Overexpression of chromosome
21 transcription factor ETS2 induces neuronal apoptosis. Neurobiol
Dis 2003; 14: 349-356.
12. Head E, Lott IT. Down syndrome and beta-amyloid
deposition. Curr Opin Neurol 2004;17: 95-100.
13. Reymond A, Marigo V, Yaylaoglu MB, Leoni A,
Ucla C, Scamuffa N, et al. Human chromosome 21 gene expression atlas
in the mouse. Nature 2002; 420: 582-585.
14. Epstein CJ, Avraham KB, Smith S, Elroy-Stein
O, Lovett M, Rotman G, et al. Transgenic mice with increased Cu/Zn
superoxide dismutase activity: animal model of dosage effect in Down
syndrome. Proc Natl Acad Sci 1987; 84: 8044-8048.
15. Whitaker-Azmatia PM, Wingats M, Borella A,
Gerlai R, Roder J, Azmitia EC. Transgenic mice over-expressing the
neurotrophic factor S100 beta show neuronal cytoskeletal and
behavioral signs of altered aging process: implication of
Alzheimer’s disease and Down’s syndrome. Brain Res 1997; 776(1-2):
51-60.
16. Sturchler-Pierrat C, Abramowski D, Duke M,
Wiedderhold KH, Mistl C, Rothacher S, et al. Two amyloid precursor
protein transgenic models with Alzheimer disease like pathology.
Proc Natl Acad Sci 1997; 94: 13287-13292.
17. Sumarsono S, Wilson TJ, Tymms MJ, Venter DJ,
Corrick CM, Kol R, et al. Down syndrome like skeletal abnormalities
in Ets2 transgenic mice. Nature 1996; 379: 534-537.
18. Martinez de LM, Altafaj X, Gallego X, Marti
E, Estivill X, Sahun I, et al. Motor phenotypic alterations in
TgDyrk1a transgenic mice implicate DYRK1A in Down syndrome motor
dysfunction. Neurobiol Dis 2004; 15: 132-142.
19. Ema M, Ikegami S, Hosoya T, Mimura J, Ohtani
H, Nakao K, et al. Mild impairment of learning and memory in mice
over expressing the mSim2 gene located on chromosome 16: An animal
model of Down syndrome. Hum Mol Genet 1999; 8: 409- 415.
20. Epstein CJ, Cox DR, Epstein LB. Mouse Trisomy
16: An animal model of human trisomy 21(Down Syndrome). Ann NY Acad
Sci 1985; 450: 157-168.
21. Davisson MT, Schmidt C, Akeson EC. Segmental
trisomy for murine chromosome 16: A new system for studying Down
syndrome. Prog Clin Biol Res. 1990; 360:263-280.
22. Sago H, Carlson EJ, Smith DJ, Kilbridge J,
Rubin EM, Mobley WC, et al. Ts1Cje, a partial trisomy 16 mouse model
for Down syndrome, exhibit learning and behavioral abnormalities.
Proc Natl Acad Sci 1998; 95: 6256-6261.
23. Cooper JD, Salehi A, Delcroix JD, Howe CL,
Belichenko PV, Couzens JC, et al. Failed retrograde transport of NGF
in s mouse model of Down’s syndrome: Reversal of cholinergic
neurodegenerative phenotypes following NGF infusion. Proc Natl Acad
Sci, 2001; 98: 10439-10444.
24. Sago H, Carlson EJ, Smith DJ, Rubin EM, Crnic LS, Huang TT,
et al. Genetic dissection of region associated with behavioral
abnormalities in mouse model of Down syndrome. Pediatr Res 2000; 48:
606-613.